Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,074 public trials 1,776 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

RT001 in Amyotrophic Lateral Sclerosis

NCT04762589

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of Tartu Tartu, Estonia
  • Riga Stradins Universtiy Riga, Latvia
  • UMC Utrecht Utrecht, Netherlands
  • Karolinska Stockholm, Sweden
View Trial Details
Completed

Sing for Your Saunter

NCT04246476

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Washington University School of Medicine Program in Physical Therapy St Louis, Missouri, United States
View Trial Details
Completed

TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects

NCT03237494

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +20 more
Locations
  • Kepler Universitätsklinikum, Klinik für Interne 1 - Kardiologie und internistische Intensivmedizin; Cardiology Linz, Austria
  • Kepler Universitätsklinikum, Neuromed Campus; Neurology Linz, Austria
  • Universitätsklinikum Aachen, Neurology Aachen, Germany
  • Klinikum Westmünsterland GmbH, I. Medizinische Klinik und Interventionelle Kardiologie Ahaus, Germany
View all 84 locations
View Trial Details
Completed

Study of SPG302 in Healthy Volunteers and ALS Participants

NCT05882695

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Macquarie University North Ryde, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Herston, Queensland, Australia
  • Flinders Medical center Adelaide, South Australia, Australia
  • Nucleus Melbourne (healthy volunteers) Melbourne, Victoria, Australia
View Trial Details
Completed

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

NCT01226316

Conditions
AKT1, Adnexal Diseases, Advanced Solid Malignancy, +46 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Stanford, California, United States
  • Research Site West Hollywood, California, United States
  • Research Site Aurora, Colorado, United States
View all 34 locations
View Trial Details

Related conditions